Belgium· BE-AMP-SAM666068-00
Arexvy
A respiratorisches-synzytial-virus impfstoffe product containing recombinant respiratory syncytial virus pre-fusion f protein, adjuvanted with as01e, registered in Belgium by GlaxoSmithKline Biologicals. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Respiratorisches-synzytial-virus impfstoffe is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BX05 (respiratorisches-synzytial-virus impfstoffe), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Respiratorisches-synzytial-virus impfstoffe · ATC J07BX05
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Recombinant Respiratory Syncytial Virus Pre-fusion F Protein, Adjuvanted with AS01E
- Manufacturer
- GlaxoSmithKline Biologicals
- Country
- Belgium (BE)
- ATC code
- J07BX05
- ATC class
- Respiratorisches-Synzytial-Virus Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX05
Respiratorisches-synzytial-virus impfstoffe, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ddaa7062-fd2d-4f61-9df0-6a5c2c838110 GET /v1/drugs/ddaa7062-fd2d-4f61-9df0-6a5c2c838110?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and suspension for suspension for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Arexvy",
"name_fr": "Arexvy",
"name_nl": "Arexvy",
"amp_code": "SAM666068-00",
"strengths": [
"120.0000",
"120.0000",
"0.2000"
],
"pack_count": 2,
"substances": [
"Recombinant Respiratory Syncytial Virus Pre-fusion F Protein, Adjuvanted with AS01E",
"Dipotassium Hydrogen Phosphate",
"Disodium Phosphate",
"Potassium Dihydrogen Phosphate",
"Sodium Chloride",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Respiratory Syncytial Virus Vaccines",
"authorisation_numbers": [
"EU/1/23/1740/004",
"EU/1/23/1740/003"
]
}See everything about respiratorisches-synzytial-virus impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.